City State Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$412 742
2024
Q3
$412 Hold
100
﹤0.01% 703
2024
Q2
$652 Hold
100
﹤0.01% 680
2024
Q1
$1K Hold
100
﹤0.01% 685
2023
Q4
$1K Hold
100
﹤0.01% 655
2023
Q3
$1K Hold
100
﹤0.01% 665
2023
Q2
$1K Hold
100
﹤0.01% 674
2023
Q1
$1K Hold
100
﹤0.01% 654
2022
Q4
$1K Hold
100
﹤0.01% 633
2022
Q3
$1K Hold
100
﹤0.01% 638
2022
Q2
$1K Hold
100
﹤0.01% 642
2022
Q1
$1K Hold
100
﹤0.01% 658
2021
Q4
$1K Buy
+100
New +$1.23K ﹤0.01% 646

Other funds holding IRWD

City State Bank's IRWD Position: Q4 2024 in Review

City State Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 100 shares — an estimated $412 sold.

City State Bank first reported a position in IRWD in Q4 2021 and held it in 12 quarters. The position peaked at $1K in Q1 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • City State Bank reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • City State Bank sold 100 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $412.
  • City State Bank first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • City State Bank's Ironwood Pharmaceuticals position peaked at $1K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on City State Bank's 13F filing for Q4 2024, filed 13 Jan 2025.